[Congressional Bills 107th Congress]
[From the U.S. Government Publishing Office]
[S. 2558 Referred in House (RFH)]

  2d Session
                                S. 2558


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           September 4, 2002

            Referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 AN ACT


 
To amend the Public Health Service Act to provide for the collection of 
  data on benign brain-related tumors through the national program of 
                           cancer registries.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Benign Brain Tumor Cancer Registries 
Amendment Act''.

SEC. 2. NATIONAL PROGRAM OF CANCER REGISTRIES; BENIGN BRAIN-RELATED 
              TUMORS AS ADDITIONAL CATEGORY OF DATA COLLECTED.

    (a) In General.--Section 399B of the Public Health Service Act (42 
U.S.C. 280e), as redesignated by section 502(2)(A) of Public Law 106-
310 (114 Stat. 1115), is amended in subsection (a)--
            (1) by redesignating paragraphs (1) through (5) as 
        subparagraphs (A) through (E), respectively and indenting 
        appropriately;
            (2) by striking ``(a) In General.--The Secretary'' and 
        inserting the following:
    ``(a) In General.--
            ``(1) Statewide cancer registries.--The Secretary'';
            (3) in the matter preceding subparagraph (A) (as so 
        redesignated), by striking ``population-based'' and all that 
        follows through ``data'' and inserting the following: 
        ``population-based, statewide registries to collect, for each 
        condition specified in paragraph (2)(A), data''; and
            (4) by adding at the end the following:
            ``(2) Cancer; benign brain-related tumors.--
                    ``(A) In general.--For purposes of paragraph (1), 
                the conditions referred to in this paragraph are the 
                following:
                            ``(i) Each form of in-situ and invasive 
                        cancer (with the exception of basal cell and 
                        squamous cell carcinoma of the skin), including 
                        malignant brain-related tumors.
                            ``(ii) Benign brain-related tumors.
                    ``(B) Brain-related tumor.--For purposes of 
                subparagraph (A):
                            ``(i) The term `brain-related tumor' means 
                        a listed primary tumor (whether malignant or 
                        benign) occurring in any of the following 
                        sites:
                                    ``(I) The brain, meninges, spinal 
                                cord, cauda equina, a cranial nerve or 
                                nerves, or any other part of the 
                                central nervous system.
                                    ``(II) The pituitary gland, pineal 
                                gland, or craniopharyngeal duct.
                            ``(ii) The term `listed', with respect to a 
                        primary tumor, means a primary tumor that is 
                        listed in the International Classification of 
                        Diseases for Oncology (commonly referred to as 
                        the ICD-O).
                            ``(iii) The term `International 
                        Classification of Diseases for Oncology' means 
                        a classification system that includes 
                        topography (site) information and histology 
                        (cell type information) developed by the World 
                        Health Organization, in collaboration with 
                        international centers, to promote international 
                        comparability in the collection, 
                        classification, processing, and presentation of 
                        cancer statistics. The ICD-O system is a 
                        supplement to the International Statistical 
                        Classification of Diseases and Related Health 
                        Problems (commonly known as the ICD) and is the 
                        standard coding system used by cancer 
                        registries worldwide. Such term includes any 
                        modification made to such system for purposes 
                        of the United States. Such term further 
                        includes any published classification system 
                        that is internationally recognized as a 
                        successor to the classification system referred 
                        to in the first sentence of this clause.
                    ``(C) Statewide cancer registry.--References in 
                this section to cancer registries shall be considered 
                to be references to registries described in this 
                subsection.''.
    (b) Applicability.--The amendments made by subsection (a) apply to 
grants under section 399B of the Public Health Service Act for fiscal 
year 2002 and subsequent fiscal years, except that, in the case of a 
State that received such a grant for fiscal year 2000, the Secretary of 
Health and Human Services may delay the applicability of such 
amendments to the State for not more than 12 months if the Secretary 
determines that compliance with such amendments requires the enactment 
of a statute by the State or the issuance of State regulations.

            Passed the Senate August 1, 2002.

            Attest:

                                                  JERI THOMSON,

                                                             Secretary.